Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Raaz

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Journal of Thrombosis and Thrombolysis|July 21, 2011
Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro studyAnja Kaeberich, Iris Reindl, Uwe Raaz, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 25, 2011
Massive ascites generation following pacemaker infection: a case reportUwe Raaz, Michael Buerke, Dietrich Stoevesandt, et al.
Thrombosis and Haemostasis|June 4, 2009
Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro studyLars Maegdefessel, Torsten Linde, Thomas Michel, et al.
The Journal of Endocrinology|May 1, 2025
Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1Priyanka Boettger, Laura Pallmann, Patrick Kellner, et al.
Lipids|January 29, 2010
Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetesAxel Schlitt, Bernhard Schwaab, Kirsten Fingscheidt, et al.
The Journal of Clinical Investigation|May 2, 2019
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosisYoko Kojima, Kelly Downing, Ramendra Kundu, et al.
Diabetology & Metabolic Syndrome|January 26, 2023
miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitusMelanie S Hulshoff, Isabel N Schellinger, Xingbo Xu, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|May 8, 2023
Abdominal Aortic Endograft Implantation Immediately Induces Vascular Stiffness Gradients That May Promote Adverse Aortic Neck Dilatation: Results of A Porcine <i>Ex Vivo</i> StudyIsabel N Schellinger, Jörg Naumann, Annett Hoffmann, et al.
Journal of Lipid Research|November 13, 2008
PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene studyAxel Schlitt, Stefan Blankenberg, Christoph Bickel, et al.
The Journal of Clinical Investigation|February 18, 2014
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosisYoko Kojima, Kelly Downing, Ramendra Kundu, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Thrombolysis|July 21, 2011
Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro studyAnja Kaeberich, Iris Reindl, Uwe Raaz, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 25, 2011
Massive ascites generation following pacemaker infection: a case reportUwe Raaz, Michael Buerke, Dietrich Stoevesandt, et al.
Thrombosis and Haemostasis|June 4, 2009
Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro studyLars Maegdefessel, Torsten Linde, Thomas Michel, et al.
The Journal of Endocrinology|May 1, 2025
Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1Priyanka Boettger, Laura Pallmann, Patrick Kellner, et al.
Lipids|January 29, 2010
Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetesAxel Schlitt, Bernhard Schwaab, Kirsten Fingscheidt, et al.
The Journal of Clinical Investigation|May 2, 2019
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosisYoko Kojima, Kelly Downing, Ramendra Kundu, et al.
Diabetology & Metabolic Syndrome|January 26, 2023
miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitusMelanie S Hulshoff, Isabel N Schellinger, Xingbo Xu, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|May 8, 2023
Abdominal Aortic Endograft Implantation Immediately Induces Vascular Stiffness Gradients That May Promote Adverse Aortic Neck Dilatation: Results of A Porcine <i>Ex Vivo</i> StudyIsabel N Schellinger, Jörg Naumann, Annett Hoffmann, et al.
Journal of Lipid Research|November 13, 2008
PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene studyAxel Schlitt, Stefan Blankenberg, Christoph Bickel, et al.
The Journal of Clinical Investigation|February 18, 2014
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosisYoko Kojima, Kelly Downing, Ramendra Kundu, et al.
Pageof 6